Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01574573 · ClinicalTrials.gov registry record · NA
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study
A NA study, sponsored by Midwest Biomedical Research Foundation.
- Terminated
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT01574573 is a NA study that was terminated before completion, run by Midwest Biomedical Research Foundation. The registered enrollment target is 52 participants.
The verdict
NCT01574573, a NA study, was terminated before completion, sponsored by Midwest Biomedical Research Foundation.
- TERMINATED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
By affecting the gastroesophageal pressure gradient, obesity predisposes to reflux of gastric contents. The investigators hypothesized that the loss of weight will decrease this gradient and as a result decrease the severity and frequency of GERD symptoms. GERD negatively affects health related quality of life. Since loss of weight may decrease gastroesophageal reflux, the investigators hypothesized that it obesity contributes to poor quality of life in GERD subjects and losing weight should also favorably impact and improve quality of life in GERD patients.
Interventions
- BEHAVIORAL Self support, group sessions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2009-06 |
| Est. Completion | 2017-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01574573
The ClinicalTrials.gov registry entry for NCT01574573 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Midwest Biomedical Research Foundation, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Self support, group sessions is the first listed.
NCT01574573 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01574573 about?
NCT01574573 is a clinical study titled "Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study". By affecting the gastroesophageal pressure gradient, obesity predisposes to reflux of gastric contents. The investigators hypothesized that the loss of weight will decrease this gradient and as a result decrease the severity and frequency of GERD symptoms. GERD negatively affects health related qual...
What is the current status of trial NCT01574573?
This trial is currently terminated. It is a NA study. The enrollment target is 52 participants. The study started on 2009-06. Estimated completion is 2017-05.
What interventions are being tested in trial NCT01574573?
The interventions under investigation include: Self support, group sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT01574573?
This trial is sponsored by Midwest Biomedical Research Foundation, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.